1. Home
  2. POET vs ZLAB Comparison

POET vs ZLAB Comparison

Compare POET & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POET Technologies Inc.

POET

POET Technologies Inc.

SELL

Current Price

$8.08

Market Cap

1.6B

Sector

Technology

ML Signal

SELL

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$22.30

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POET
ZLAB
Founded
1972
2013
Country
Canada
China
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2008
2017

Fundamental Metrics

Financial Performance
Metric
POET
ZLAB
Price
$8.08
$22.30
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$49.60
AVG Volume (30 Days)
28.5M
648.8K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.46
EPS
N/A
N/A
Revenue
N/A
$460,156,000.00
Revenue This Year
$848.96
$9.75
Revenue Next Year
$700.00
$26.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.33
52 Week Low
$3.79
$15.96
52 Week High
$15.50
$44.34

Technical Indicators

Market Signals
Indicator
POET
ZLAB
Relative Strength Index (RSI) 49.88 54.14
Support Level $5.40 $16.88
Resistance Level $9.14 $25.28
Average True Range (ATR) 1.37 0.87
MACD 0.19 -0.14
Stochastic Oscillator 21.64 37.47

Price Performance

Historical Comparison
POET
ZLAB

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: